KamRAB - HRIG
Phase 3Completed 0 views this week 0 watching💤 Quiet
Interest: 34/100
34
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedAbout KamRAB - HRIG
KamRAB - HRIG is a phase 3 stage product being developed by Kamada for Rabies. The current trial status is completed. This product is registered under clinical trial identifier NCT02912845. Target conditions include Rabies.
What happened to similar drugs?
2 of 14 similar drugs in Rabies were approved
Approved (2) Terminated (0) Active (12)
Hype Score Breakdown
Clinical
17
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02912845 | Phase 3 | Completed |
Competing Products
20 competing products in Rabies